C3, located in Albuquerque, NM, is focusing on the development and testing of cancer treatment technology that takes advantage of the fact that all cells have an electrical process and adjacent cells communicate with one another.  The approach of C3 is geared toward this cancer cell communication and “wrecking" this cancer cell communication network through tiny pico-sparks defined as “Codes-of-Death” to disrupt this cancer cell communication network.  

C3’s initial focus is the development of neuro-signaling communication to those malignant cancer cells to offer a unique treatment modality that is expected not to disturb normal adjacent structures and cells.  It is this neuro-signaling disrupting cancer cell communication that C3 intends to affect and cause cancer cell apoptosis rapidly.